S. Damodaran, F. Meric-Bernstam, K. Hess, J. Litton, V. Raymond, R. Lanman, N. Ueno, S. Hamilton, I. Wistuba, V. Valero, S. Moulder, D. Tripathy
{"title":"摘要:INTERACT-利用循环肿瘤DNA对激素受体(HR)阳性转移性乳腺癌(MBC)的耐药性和可操作性进行综合评估","authors":"S. Damodaran, F. Meric-Bernstam, K. Hess, J. Litton, V. Raymond, R. Lanman, N. Ueno, S. Hamilton, I. Wistuba, V. Valero, S. Moulder, D. Tripathy","doi":"10.1158/1538-7445.SABCS18-OT1-03-04","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19476,"journal":{"name":"Ongoing Clinical Trials","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Abstract OT1-03-04: INTERACT- INTegrated Evaluation of Resistance and Actionability using Circulating Tumor DNA in hormone receptor (HR) positive metastatic breast cancers (MBC)\",\"authors\":\"S. Damodaran, F. Meric-Bernstam, K. Hess, J. Litton, V. Raymond, R. Lanman, N. Ueno, S. Hamilton, I. Wistuba, V. Valero, S. Moulder, D. Tripathy\",\"doi\":\"10.1158/1538-7445.SABCS18-OT1-03-04\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19476,\"journal\":{\"name\":\"Ongoing Clinical Trials\",\"volume\":\"3 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ongoing Clinical Trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.SABCS18-OT1-03-04\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ongoing Clinical Trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.SABCS18-OT1-03-04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract OT1-03-04: INTERACT- INTegrated Evaluation of Resistance and Actionability using Circulating Tumor DNA in hormone receptor (HR) positive metastatic breast cancers (MBC)